Assoc Director, Medical Affairs at Gilead Sciences

Sao Paulo, Sao Paulo, Brazil

Gilead Sciences Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Pharmaceuticals, OncologyIndustries

Requirements

  • Provides local medical expert input into global product development for Kite
  • Represents the company to groups of experts, medical professional groups, societies, regulatory groups at international and national scientific meetings
  • Develops and leads plans with national cooperative groups to define gaps and potential specific national requirements/needs
  • Supports the development of local complex clinical data through clinical trials and investigator studies
  • Supports the development of Health Economic Outcome Research programs for the country
  • Contributes to the development of the Market access Strategy in coordination with the Market Access, Regulatory affairs, Business Unit Director; delivers the medical part of the plan
  • Manages the local Medical Affairs function
  • Develops and executes Medical pre-launch and post-launch Medical plan
  • Oversees/controls Medical Budget (+/-5% spent)
  • Provides Medical strategic direction and vision and works as a team with the Business Unit Director and Market Access Director
  • Is part of the International region Medical Affairs team and contributes to the overall International region strategy and efforts
  • Leads data generation projects where applicable
  • Maintains regular communication with external medical community to remain abreast of issues in the field and to provide medical support and direction
  • Engages in peer-to-peer scientific exchange of complex clinical and scientific information
  • Develops and fosters strong scientific relationships

Responsibilities

  • Builds and oversees strategies and tactics for Cell Therapy within the Kite Brazil Medical Affairs Department
  • Provides strategic leadership for all Medical Affairs activities
  • Develops and executes Medical Affairs strategic initiatives in Brazil
  • Reports to the Kite International Region Head of Medical Affairs

Skills

Medical Affairs
Cell Therapy
Immunotherapy
T Cell Therapy
Strategic Leadership
Medical Strategy

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters
1987Year Founded
$15,873.6MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Paid family time off and paid parental time off
Generous 401(k) contribution matching
Comprehensive medical plans that cover both physical and mental healthcare
Global Wellbeing Reimbursement
Time Off
Global Volunteer Day
Giving Together Program
Employee Support Programs
Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.
Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.
Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.
Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.
Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.
Investment in digital health technologies enhances Gilead's R&D and patient engagement.
Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI